Becoming
international

We are the 1st Japanese generic and value-added medicines (VAMs) medicines company in Europe and USA.
From this foundation, we continue expanding into new markets and regions with one clear goal: to make high-quality, accessible medicines available to as many people as possible worldwide.
We are part of Towa Pharmaceutical, the leading generic medicines company in Japan. Since our acquisition in 2020, Towa International has been the Group’s global growth engine, responsible for driving international expansion beyond Japan.
With a solid base in Europe and the U.S., we are rapidly expanding our international presence. Across the Towa Group, we are committed to delivering medicines that are needed by patients worldwide.
Guided by our vision of “contribution to people’s health,” we are using our platform in several European countries and the United States as well as the production bases in Europe compliant with the European and American quality standards to:

  1. Expand our global presence through sustainable, long-term growth.

  2. Deliver our value-added medicines to people worldwide.

  3. Maintain and enhance our competitiveness by launching new products based
    on the specific needs of each market.

Our international operations are anchored in Japan, the United States, and Europe. Building on this tri-regional foundation, we continue to explore and invest in new opportunities across other regions, reinforcing our commitment to delivering high-
quality, value-added medicines to patients worldwide.

Our global presence